APOE and Alzheimer disease: The AUC values for the plasma biomarkers and AD clinical factors (age, sex, BMI, years of education, and APOE ε4 carrier status) were compared across participants with different cognitive levels to measure the diagnostic value of these parameters in the AD continuum (Fig. 3).